GRAS INDEPENDENT DETERMINATIONS BY MANUFACTURERS WILL BE CONSIDERED BY FDA
This article was originally published in The Tan Sheet
Executive Summary
GRAS INDEPENDENT DETERMINATIONS BY MANUFACTURERS WILL BE CONSIDERED BY FDA in determining whether a dietary supplement ingredient is safe, the agency said in the final rule for dietary supplement health claims published in the Jan. 4 Federal Register. FDA said it "intends to consider the basis of manufacturers' independent determinations [when] submitted with petitions for health claims and may use its discretion to accept, without formal affirmation, the independent determination of GRAS [generally recognized as safe] where FDA believes such action would be appropriate."